News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News Charity raises funds for legal fight over HIV drug National AIDS Trust continues legal battle over Truvada.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
